Gw Pharma ADR (GWPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -117,490 | -62,619 | -19,250 | N/A | -62,173 |
| Depreciation Amortization | 5,137 | 3,004 | 1,329 | N/A | 3,415 |
| Accounts receivable | -2,490 | -2,089 | -2,436 | N/A | 76 |
| Other Working Capital | 21,026 | -9,247 | 2,895 | N/A | 20,994 |
| Other Operating Activity | -4,174 | -11,737 | -12,148 | 0 | -38,326 |
| Operating Cash Flow | $-97,991 | $-82,688 | $-29,610 | $N/A | $-76,014 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -16,896 | -11,274 | -1,698 | N/A | -8,319 |
| Purchase Sale Intangibles | -609 | -536 | -272 | N/A | -483 |
| Other Investing Activity | 653 | 12 | -102 | 0 | -97 |
| Investing Cash Flow | $-16,243 | $-11,262 | $-1,800 | $N/A | $-8,416 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | -130 |
| Debt Repayment | -208 | -103 | -117 | N/A | N/A |
| Common Stock Issued | 118 | -55 | 111 | N/A | 845 |
| Other Financing Activity | -2,095 | -1,401 | -1,166 | 0 | -389 |
| Financing Cash Flow | $-2,185 | $-1,559 | $-1,172 | $N/A | $326 |
| Exchange Rate Effect | -1,053 | 10,150 | 15,123 | N/A | 25,993 |
| Beginning Cash Position | 487,011 | 469,229 | 462,108 | N/A | 312,363 |
| End Cash Position | 369,539 | 383,870 | 444,649 | N/A | 254,252 |
| Net Cash Flow | $-117,472 | $-85,359 | $-17,459 | $N/A | $-58,111 |
| Free Cash Flow | |||||
| Operating Cash Flow | -97,991 | -82,688 | -29,610 | N/A | -76,014 |
| Capital Expenditure | -16,896 | -11,274 | -1,698 | N/A | -8,319 |
| Free Cash Flow | -114,887 | -93,962 | -31,308 | 0 | -84,333 |